At Hawaiian Eye, Steve G. Yoelin, MD, shares pearls for using neuromodulators and toxins in the ophthalmic practice.
Author: Healio ophthalmology
Bilateral, contralateral multifocal IOLs yield similar intermediate, distance visual acuity
Bilateral implantation of a multifocal IOL was non-inferior to contralateral implantation of different multifocal IOLs in terms of intermediate and distance visual acuity, according to a study. However, bilateral implantation did not yield comparable near vision.“These results suggest that contralateral implantation might have a higher likelihood than bilateral implantation of patients attaining spectacle independence over a wide range of distances,” the study authors said.
VIDEO: Boston keratoprosthesis in severe external disease
The Boston keratoprosthesis technique may be a good option in the surgical management of severe external disease. In this particular case with severe pemphigoid, almost ankyloblepharon, cornea scarring and dense cataract, we performed a combined symble…
VIDEO: Lights and lasers for the ophthalmologist
At Hawaiian Eye, Roger A. Dailey, MD, FACS, discusses available lights and lasers that ophthalmologists can use in their practice.
Advances in regenerative medicine may alter treatment of corneal endothelial diseases
The last decade has seen significant advances in the field of corneal surgery. Various lamellar keratoplasty techniques have been refined, and endothelial keratoplasty in the form of Descemet’s stripping automated endothelial keratoplasty has now become the standard for endothelial diseases. Worldwide, DSAEK is now one of the most common techniques for endothelial transplant, with excellent functional outcomes.However, Descemet’s membrane endothelial keratoplasty, with its better functional results and faster visual recovery, is now challenging DSAEK. The concern with DMEK is the handling of the delicate Descemet’s membrane and endothelium and the (Read more...)
Optic disc, macular changes common in highly myopic young Asian adults
Changes in the optic disc and macula were prevalent in highly myopic eyes in a young Asian adult population, a study found.Investigators prospectively analyzed 593 highly myopic subjects and a comparator group of 156 emmetropic subjects. All subjects w…
VIDEO: Surgeon shares pearls on managing common cataract complications
BASSANO DEL GRAPPA, Italy — At the Bassano Ophthalmology Meeting, Daniele Tognetto, MD, gives basic pearls on how to deal with the most common complications during cataract surgery.
VIDEO: Surgeon shares pearls on managing common cataract complications
BASSANO DEL GRAPPA, Italy — At the Bassano Ophthalmology Meeting, Daniele Tognetto, MD, gives basic pearls on how to deal with the most common complications during cataract surgery.
VIDEO: Topicals and peels for the face
At Hawaiian Eye, Joely Kaufman, MD, FAAD, discusses the benefits of incorporating topical medications and peels for minimally invasive cosmetic surgery.
Alcon, PowerVision enter strategic alliance to develop accommodating IOL
Alcon has entered into a strategic alliance with PowerVision, according to an Alcon press release.PowerVision has developed an accommodating IOL that has shown the ability in pilot studies to change focus through fluid-driven shape-changing technology. The IOL is for cataract patients with presbyopia, and it is implanted in the capsular bag and utilizes the eye’s natural accommodating muscles to transport fluid in the IOL.
Physician behaviors hinder patients in navigating out-of-pocket costs
Recent qualitative findings published in Health Affairs showed that physicians struggled to help patients factor out-of-pocket expenses into their medical decisions.“Health care consumers cannot expect to make savvy financial decisions if their doctors do not engage with them in productive conversations about the pros and cons of their health care alternatives, including the financial costs,” Peter A. Ubel, MD, professor in the Sanford School of Public Policy at Duke University, told Healio Internal Medicine. “Some physicians say they are reluctant to do so because money talk would contaminate the doctor-patient (Read more...)
Keranova raises €4 million in series A funding for prototype in automated surgery
Keranova reported a series A funding investment of 4 million to finance development of prototype ophthalmic surgical equipment, according to a press release.The technological innovation “allows for a substantial reduction in manual intervention in favor of automation and precision,” which reduces operator-dependent risk, according to the release.
Nicox submits new drug application for AC-170
Nicox has submitted a new drug application to the FDA for AC-170 to treat ocular itching associated with allergic conjunctivitis, according to a press release. The company also requested a priority review based on clinical pediatric data generated with…
FDA approves Avedro’s cross-linking system for progressive keratoconus
The FDA has approved the KXL System and two photoenhancers for corneal collagen cross-linking treatment of progressive keratoconus, according to a press release from Avedro.The photoenhancers are Photrexa 0.146%, a riboflavin 5’-phosphate solution, and Photrexa Viscous 0.146%, a riboflavin 5’-phosphate in 20% dextran ophthalmic solution.
American Society of Ophthalmic Plastic and Reconstructive Surgery names new president
The American Society of Ophthalmic Plastic and Reconstructive Surgery announced in a press release it has named Robert Alan Goldberg, MD, as president.Goldberg, professor of ophthalmology at the David Geffen School of Medicine and UCLA and chief of orb…
Physicians lack clarity on FDA approvals, ‘breakthrough therapy’
Physicians demonstrated limited understanding of the FDA approval process and the meaning of the “breakthrough therapy” designation, according to recent research in JAMA.“Although the term ‘breakthrough’ leads consumers to overly optimistic beliefs about drug effectiveness, it is not known how physicians understand this term — or more generally, what FDA approval means,” Aaron S. Kesselheim, MD, JD, MPH, of the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Women’s Hospital, and colleagues wrote. “A national survey of board-certified internists and specialists revealed substantial deficits in knowledge of the meaning of (Read more...)
Twice-daily dose of trabodenoson may lower IOP in glaucoma patients
Twice-daily 50 µg to 500 µg ocular doses of trabodenoson were well-tolerated, according to a study, and at 500 µg, a dose-related decrease in IOP was seen in patients with primary open-angle glaucoma or ocular hypertension.The multicenter, randomized, double-masked, placebo-controlled, dose-escalation phase 2 study included 141 patients who were administered 50 µg, 100 µg or 200 µg unilateral topical twice-daily trabodenoson (Inotek Pharmaceuticals) or placebo for 14 days, or 500 µg trabodenoson or placebo for 28 days.
Ohr enrolls first patient in phase 3 clinical trial of squalamine for wet AMD
Ohr Pharmaceutical has enrolled the first patient in the first of two phase 3 clinical trials of squalamine lactate ophthalmic solution 0.2% for the treatment of neovascular age-related macular degeneration, according to a press release. The phase 3 cl…
VIDEO: New generation of ophthalmologists embrace technological advancements in glaucoma
BASSANO DEL GRAPPA, Italy — At the Bassano Ophthalmology Meeting, OSN Europe Editorial Board Member Stefano Gandolfi, MD, relates one of the commendable “pros” of the meeting: a cross-generational discussion on technological advancements in the management of complications in glaucoma surgery, which included skills and insights of senior ophthalmologists and of new-generation surgeons.
Bowman’s layer transplantation may be safer surgery for patients with advanced keratoconus
For most eyes with advanced keratoconus, penetrating keratoplasty is a bad option. It permanently weakens the cornea, precipitates cataracts, promotes glaucoma, provides an often uneven and unstable refractive surface, presents the constant risk of allograft reaction and graft rejection, and — perhaps worst of all — produces many unhappy patients, particularly if the surgery was elective and not emergently required.Nevertheless, PK so far remains the most common surgical treatment worldwide for patients with advanced keratoconus. And while alternatives to conventional PK have emerged, including deep anterior lamellar keratoplasty and new (Read more...)